Try our Advanced Search for more refined results
December 22, 2009
In re GENZYME CORP. DERIVATIVE LITIGATION
Case Number:
1:09-cv-12170
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 01, 2011
Genzyme Seeks Toss Of Investors' Insider Trading Suit
Genzyme Corp. has asked a federal judge to dismiss a shareholder suit that accuses company executives of misleading the U.S. Food and Drug Administration and selling $117 million worth of stock based on nonpublic information.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login